The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.
Mouse model.
I have talked about this a few times.
The survival rate of the D14 is similar to early response from the trial.
Hopefully this means 100% positive reaction to Modi1 in early stage patients.
It is my understanding that abstracts have to be submitted in advanced.
I know that the most recent had to be submitted in February and I believe the previous one was similar.
I do except an full update soon.
Thought it might have been at 12 weeks. Could be 16 or sooner
If we can increase the number of patients who responded to CPI with our treatments this would be massive.
With low take up rates of CPI we could add billions of revenue every year.
If we sold exclusive to one manufacturer they could combine the two and add to the patent life by year's
Well its not the SP today or even next week.
With the funding they have its to advance the products they have developed and then sell them for as much as they can.
the board have done a £600m deal and have two products in advanced trials.
It is defently not their fault the SP has dropped to 15p
They need it done to raise money to pay for drilling.
It's not being rushed through because MFC results are not as hopped!!
In truth the board will only care what the SP is when they need to raise money.
Other than that they don't care if it's 1p or 2p.
If they do find big the SP will take care of its self
One is revenue will start next month when feed stock starts to arrive and we get the gate fee,!
Two. The numbers talked about are based on a single shift 5 days a week.
They have mentioned this a few times!!!
Strongly believe we will see the plant working a lot longer hours in a couple of months.
Could easily be 50% more by the year end